Nuwellis (NUWE) EBIT Margin (2013 - 2026)
Nuwellis' (NUWE) quarterly EBIT Margin came in at 160.94% in Q2 2026, up 752.0% on a YoY basis from 18.89% in Q2 2025, and up 15.33% quarter-over-quarter from 190.1% in Q1 2026.
Powered by 
Analysis
Nuwellis (NUWE) EBIT Margin (2013 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported EBIT Margin for 14 consecutive years, with 160.94% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBIT Margin rose 752.0% year-over-year to 160.94%; the trailing twelve-month figure through Jun 2026 stood at 142.87% (down 2403.0% YoY), and the FY2025 full-year result was 134.29%, down 857.0% from the prior year.
- EBIT Margin grew to 160.94% in Q2 2026 per NUWE's latest filing, from 190.1% in the prior quarter.
- Across five years, EBIT Margin topped out at 64.72% in Q3 2024 and bottomed at 320.43% in Q1 2023.
- Historically, EBIT Margin has averaged 170.75% across 5 years, with a median of 164.7% in 2025.
- The sharpest annual moves came in 2023 and 2024: EBIT Margin tumbled 9114 bps in 2023, then surged 13628 bps in 2024.
- Over 5 years, EBIT Margin stood at 193.84% in 2022, then increased by 27 bps to 140.85% in 2023, then increased by 27 bps to 102.8% in 2024, then increased by 2 bps to 100.78% in 2025, then sank by 60 bps to 160.94% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 160.94%, 190.1%, and 100.78% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 19.15% |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | -160.94% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -160.94% |
| Mar 31, 2026 | -190.10% |
| Dec 31, 2025 | -100.78% |
| Sep 30, 2025 | -121.65% |
| Jun 30, 2025 | -168.46% |
| Mar 31, 2025 | -160.71% |
| Dec 31, 2024 | -102.80% |
| Sep 30, 2024 | -64.72% |
| Jun 30, 2024 | -105.74% |
| Mar 31, 2024 | -255.74% |
| Dec 31, 2023 | -140.85% |
| Sep 30, 2023 | -131.18% |
| Jun 30, 2023 | -242.02% |
| Mar 31, 2023 | -320.43% |
| Dec 31, 2022 | -193.84% |
| Sep 30, 2022 | -189.83% |
| Jun 30, 2022 | -194.35% |
| Mar 31, 2022 | -229.28% |
| Dec 31, 2021 | -263.76% |
| Sep 30, 2021 | -283.38% |